CME Presentations

Carcinoid Syndrome


  • CME

    Carcinoid Syndrome: Updates in Pathophysiology, Diagnosis, and Treatment

    Speakers:Matthew H. Kulke, MD, MMSc, Associate Professor of Medicine
    David C. Metz, MBBCh, Professor of Medicine

    Duration: 60 minutes

    Presented on: June 14, 2017


  • Matthew H. Kulke, MD, MMSc

    Matthew H. Kulke, MD, MMSc

    Matthew H. Kulke, MD, MMSc

    Associate Professor of Medicine

    Matthew Kulke, MD, MMSc, is director of the Neuroendocrine and Carcinoid Tumor Program at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School in Boston, Massachusetts. Dr Kulke has played a leading role in the molecular characterization of neuroendocrine tumors and in developing new treatments for this indication, including sunitinib, temozolomide everolimus, and telotristat ethyl. He serves on the gastrointestinal cancer committee for the Cancer and Leukemia Group B, the advisory board for the European Neuroendocrine Tumor Society, and chairs the neuroendocrine tumor guidelines panel for the National Comprehensive Cancer Network. He received his MD from the University of California, San Francisco School of Medicine and his MMSc from Harvard Medical School.
  • David C. Metz, MBBCh

    David C. Metz, MBBCh

    David C. Metz, MBBCh

    Professor of Medicine

    David C. Metz, MBBCh, is a professor of medicine and associate chief for clinical affairs in the Division of Gastroenterology at the University of Pennsylvania in Philadelphia, where he is director of the Acid-Peptic Disease Program and co-director of the GI Physiology Laboratory, the Swallowing Disorders Program and the Neuroendocrine Tumor Program. His clinical research investigates Zollinger-Ellison syndrome, H. pylori infection, nonsteroidal anti-inflammatory drug gastropathy, and gastroesophageal reflux disease. He has expertise in the diagnosis and management of patients with functional and non-functional neuroendocrine tumors of the pancreas and alimentary tract. Dr Metz earned his MBBCh (MD equivalent) from the University of the Witwatersrand in Johannesburg, South Africa.

CME Information